Literature DB >> 16401145

Neurochemistry in the pathophysiology of autism.

Christopher J McDougle1, Craig A Erickson, Kimberly A Stigler, David J Posey.   

Abstract

Significant progress has been made in the search for underlying pathophysiologic mechanisms in autism over the past 50 years. The cause of the disorder, however, remains largely unknown. This article reviews neurochemical contributions to the pathophysiology of autism with a focus on monoamines, glutamate/gamma-aminobutyric acid systems, and neuropeptides. As these efforts move forward, it will be important to begin to integrate genetic studies with those involving neuroimaging and postmortem research in each of these 3 areas, as well as with pharmacologic treatment approaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16401145

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  45 in total

Review 1.  Aripiprazole in autism spectrum disorders and fragile X syndrome.

Authors:  Craig A Erickson; Kimberly A Stigler; David J Posey; Christopher J McDougle
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 2.  Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Authors:  Logan K Wink; Martin H Plawecki; Craig A Erickson; Kimberly A Stigler; Christopher J McDougle
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

Review 3.  Early pharmacological treatment of autism: a rationale for developmental treatment.

Authors:  Terrence C Bethea; Linmarie Sikich
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

4.  Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells.

Authors:  André Quincozes-Santos; Renata Torres Abib; Marina Concli Leite; Daiane Bobermin; Victorio Bambini-Junior; Carlos-Alberto Gonçalves; Rudimar Riesgo; Carmem Gottfried
Journal:  Mol Cell Biochem       Date:  2008-04-18       Impact factor: 3.396

Review 5.  The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasis.

Authors:  Hannah C Kinney; Kevin G Broadbelt; Robin L Haynes; Ingvar J Rognum; David S Paterson
Journal:  J Chem Neuroanat       Date:  2011-05-27       Impact factor: 3.052

6.  Mouse models of autism: testing hypotheses about molecular mechanisms.

Authors:  Florence I Roullet; Jacqueline N Crawley
Journal:  Curr Top Behav Neurosci       Date:  2011

Review 7.  Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Afaf El-Ansary; Mona A El-Bana; Maryam Dadar; Jan Aaseth; Maha Hemimi; Joško Osredkar; Salvatore Chirumbolo
Journal:  J Mol Neurosci       Date:  2018-10-24       Impact factor: 3.444

8.  Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

Authors:  Kimberly A Stigler; Jonathan T Diener; Arlene E Kohn; Lang Li; Craig A Erickson; David J Posey; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-06       Impact factor: 2.576

9.  Differential effects of tryptophan depletion on emotion processing according to face direction.

Authors:  Justin H G Williams; David I Perrett; Gordon D Waiter; Stephen Pechey
Journal:  Soc Cogn Affect Neurosci       Date:  2007-12       Impact factor: 3.436

10.  Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder.

Authors:  Ivon Cuscó; Andrés Medrano; Blanca Gener; Mireia Vilardell; Fátima Gallastegui; Olaya Villa; Eva González; Benjamín Rodríguez-Santiago; Elisabet Vilella; Miguel Del Campo; Luis A Pérez-Jurado
Journal:  Hum Mol Genet       Date:  2009-02-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.